Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Gangliocytoma

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Gangliocytoma in 2 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pranzatelli, MR2
Balletti, J2

Other Studies

2 other studies available for 8-hydroxy-2-(di-n-propylamino)tetralin and Gangliocytoma

ArticleYear
Characterization of 5-hydroxytryptamine 1A-like binding sites in human ganglioneuroblastoma.
    Neuroscience letters, 1991, Oct-28, Volume: 132, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Binding Sites; Binding, Competitive; Cerebral Corte

1991
Identification of 5-HT1A recognition sites in human ganglioneuroblastoma.
    European journal of pharmacology, 1989, Oct-24, Volume: 170, Issue:1-2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Biomarkers, Tumor; Ganglioneuroma; Humans; Neurotransmitter

1989